These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28618191)

  • 1. A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.
    Dubcenco E; Beers-Block PM; Kim LP; Schotland P; Levine JG; McCloskey CA; Bashaw ED
    Clin Transl Sci; 2017 Sep; 10(5):387-394. PubMed ID: 28618191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration.
    Ren P; Cui M; Anand O; Xia L; Zhao ZJ; Sun D; Sharp T; Conner DP; Peters J; Jiang W; Stier E; Jiang X
    AAPS J; 2017 Nov; 19(6):1593-1599. PubMed ID: 28879628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton pump inhibitors and their effect on the bone].
    Ječmenová M; Kroupa R
    Vnitr Lek; 2016 Feb; 62(2):139-46. PubMed ID: 27172441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
    Lau YT; Ahmed NN
    Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton pump inhibitors (PPI): may be not as harmless as believed].
    Reinberg O
    Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of long-term PPI use.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):131-133. PubMed ID: 28787743
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.
    Ito T; Jensen RT
    Curr Gastroenterol Rep; 2010 Dec; 12(6):448-57. PubMed ID: 20882439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population.
    Zhu W; Hong K
    Int Heart J; 2017 Apr; 58(2):163-166. PubMed ID: 28321021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton pump inhibitors: not as safe as they seem].
    van Herwaarden N; Bos JM; Veldman B; Kramers C
    Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
    Lau AN; Tomizza M; Wong-Pack M; Papaioannou A; Adachi JD
    Endocrine; 2015 Aug; 49(3):606-10. PubMed ID: 25948072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.